Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults

Sao Paulo Medical Journal

Volumn 125, Issue 6, 2007, Pages 333-337

  Karnikowski, Mauro ^a   Córdova, Cláudio ^a   de Oliveira, Ricardo Jacó ^a   de Oliveira Karnikowski, Margô Gomes ^a   de Tolêdo Nóbrega, Otávio ^a  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

Author keywords

Aged; Brazil; Fatty liver; Metabolic syndrome X; Middle aged

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BRAZIL; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COMMUNITY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IDIOPATHIC DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONPARAMETRIC TEST; PATHOGENESIS; PHENOTYPE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 42249115056     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802007000600006     Document Type: Article

References (22)

1. Akbar DH, Kawther AH. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know. Med Sci Monit. 2006;12(1):RA23-6.
2. Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? Hepatology. 1998;27(6):1463-6.
3. Younossi ZM. Nonalcoholic fatty liver disease. Curr Gastroenterol Rep. 1999;1(1):57-62.
4. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology. 1994;20(6):1442-9.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report on the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
6. Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound. 1996;24(1):25-9.
7. Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006;21(1 Prt):138-43.
8. Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: and overview. J Gastroenterol Hepatol. 2002;17(11):1136-43.
9. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988;27(2):142-9.
10. Bellentani S, Saccocio G, Masutti F, et al. Prevelance of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000; 132(2):112-7.
11. Falck-Ytter Y. Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21(1):17-26.
12. Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis. 2004;8(3):501-19, vii.
13. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917-23.
14. Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol. 2004;41(6):943-9.
15. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002;17 Suppl:S186-90.
16. Kim HJ, Kim HJ, Lee, KE, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med. 2004;164(19):2169-75.
17. Sabir N, Sermez Y. Kazil S, Zencir M. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound. 2001;14(2-3):121-8.
18. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Terri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroeterology. 1994;107(4):1103-9.
19. Bashist B, Hecht HL, Harley WD. Computed tomographic demonstration of rapid changes in fatty infiltration of the liver. Radiology. 1982:142(3):691-2.
20. Chaimowicz F. A saúde dos idosos brasíleiros às vésperas do século XXI: problemas, projeções e alternatives. [Health of Brazilian elderly population on the eve of the 21st century: current problems, forecasts and alternatives]. Rev Saúde Pública = ] Public Health. 1997;31(2):184-200.
21. Nóbrega OT, Melo GF, Karnikowski MGO. Pattern of drugs prescribed for community-residing middle-aged and older adults from the outskirts of Brasília. Rev Bras Ciênc Farm 2005;41(2):271-7.
22. Foratrini OP. Qualidade de vida e meio urbano. A cidade de São Paulo, Brasil. [Quality of life and urban environment. São Paulo city. Brazil]. Rev Saúde Pública = ] Public Health. 1991; 25(2):75-86.